BARDINI, MICHELA
BARDINI, MICHELA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
2022 Zuna, J; Hovorkova, L; Krotka, J; Koehrmann, A; Bardini, M; Winkowska, L; Fronkova, E; Alten, J; Koehler, R; Eckert, C; Brizzolara, L; Trkova, M; Stuchly, J; Zimmermann, M; De Lorenzo, P; Valsecchi, M; Conter, V; Stary, J; Schrappe, M; Biondi, A; Trka, J; Zaliova, M; Cazzaniga, G; Cario, G
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
2022 Fazio, G; Bresolin, S; Silvestri, D; Quadri, M; Saitta, C; Vendramini, E; Buldini, B; Palmi, C; Bardini, M; Grioni, A; Rigamonti, S; Galbiati, M; Mecca, S; Savino, A; Peloso, A; Tu, J; Bhatia, S; Borkhardt, A; Micalizzi, C; Lo Nigro, L; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Te Kronnie, G; Biondi, A; Cazzaniga, G
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
2022 Kulp, M; Siemund, A; Larghero, P; Dietz, A; Alten, J; Cario, G; Eckert, C; Caye-Eude, A; Cave, H; Bardini, M; Cazzaniga, G; De Lorenzo, P; Valsecchi, M; Diehl, L; Bonig, H; Meyer, C; Marschalek, R
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants
2021 Fazio, G; Bardini, M; De Lorenzo, P; Grioni, A; Quadri, M; Pedace, L; Corral Abascal, L; Palamini, S; Palmi, C; Buldini, B; Vinti, L; Parasole, R; Barisone, E; Zecca, M; Favre, C; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Biondi, A; Cazzaniga, G
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturase
2020 Savino, A; Fernandes, S; Olivares, O; Zemlyansky, A; Cousins, A; Markert, E; Barel, S; Geron, I; Frishman, L; Birger, Y; Eckert, C; Tumanov, S; Mackay, G; Kamphorst, J; Herzyk, P; Fernández-García, J; Abramovich, I; Mor, I; Bardini, M; Barin, E; Janaki-Raman, S; Cross, J; Kharas, M; Gottlieb, E; Izraeli, S; Halsey, C
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis
2019 Agraz-Doblas, A; Bueno, C; Bashford-Rogers, R; Roy, A; Schneider, P; Bardini, M; Ballerini, P; Cazzaniga, G; Moreno, T; Revilla, C; Gut, M; Valsecchi, M; Roberts, I; Pieters, R; De Lorenzo, P; Varela, I; Menendez, P; Stam, R
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL
2018 Bardini, M; Trentin, L; Rizzo, F; Vieri, M; Savino, A; Castro, P; Fazio, G; Van Roon, E; Kerstjens, M; Smithers, N; Prinjha, R; Kronnie, G; Basso, G; Stam, R; Pieters, R; Biondi, A; Cazzaniga, G
Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294)
2018 Prieto, C; Lopez-Millan, B; Roca-Ho, H; Stam, R; Romero-Moya, D; Rodriguez-Baena, F; Sanjuan-Pla, A; Ayllon, V; Ramirez, M; Bardini, M; De Lorenzo, P; Valsecchi, M; Stanulla, M; Iglesias, M; Ballerini, P; Carcaboso, A; Mora, J; Locatelli, F; Bertaina, A; Padilla, L; Rodriguez-Manzaneque, J; Bueno, C; Menendez, P
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL
2018 Prieto, C; López-Millán, B; Roca-Ho, H; Stam, R; Romero-Moya, D; Rodríguez-Baena, F; Sanjuan-Pla, A; Ayllón, V; RAMIREZ BUENANO, N; Bardini, M; De Lorenzo, P; Valsecchi, M; Stanulla, M; Iglesias, M; Ballerini, P; Carcaboso, Ã; Mora, J; Locatelli, F; Bertaina, A; Padilla, L; Carlos Rodríguez-Manzaneque, J; Bueno, C; Menéndez, P
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
2018 Magnani, C; Mezzanotte, C; Cappuzzello, C; Bardini, M; Tettamanti, S; Fazio, G; Cooper, L; Dastoli, G; Cazzaniga, G; Biondi, A; Biagi, E
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL
2017 Savino, A; Sarno, J; Trentin, L; Vieri, M; Fazio, G; Bardini, M; Bugarin, C; Fossati, G; Davis, K; Gaipa, G; Izraeli, S; Meyer, L; Nolan, G; Biondi, A; Te Kronnie, G; Palmi, C; Cazzaniga, G
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis
2016 Trentin, L; Bresolin, S; Giarin, E; Bardini, M; Serafin, V; Accordi, B; Fais, F; Tenca, C; De Lorenzo, P; Valsecchi, M; Cazzaniga, G; Te Kronnie, G; Basso, G
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
2016 Muñoz-López, A; Romero-Moya, D; Prieto, C; Ramos-Mejía, V; Agraz-Doblas, A; Varela, I; Buschbeck, M; Palau, A; Carvajal-Vergara, X; Giorgetti, A; Ford, A; Lako, M; Granada, I; Ruiz-Xivillé, N; Rodríguez-Perales, S; Torres-Ruíz, R; Stam, R; Fuster, J; Fraga, M; Nakanishi, M; Cazzaniga, G; Bardini, M; Cobo, I; Bayon, G; Fernandez, A; Bueno, C; Menendez, P
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement
2015 Bardini, M; Woll, P; Corral, L; Luc, S; Wittmann, L; Ma, Z; Lo Nigro, L; Basso, G; Biondi, A; Cazzaniga, G; Jacobsen, S
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients
2015 Cazzaniga, V; Bugarin, C; Bardini, M; Giordan, M; Te Kronnie, G; Basso, G; Biondi, A; Fazio, G; Cazzaniga, G
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse
2013 Carozzi, V; Renn, C; Bardini, M; Fazio, G; Chiorazzi, A; Meregalli, C; Oggioni, N; Shanks, K; Quartu, M; Serra, M; Sala, B; Cavaletti, G; Dorsey, S
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model
2013 Meregalli, C; Carozzi, V; Canta, A; Chiorazzi, A; Sala, B; Bardini, M; Fazio, G; Cavaletti, G
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia
2013 Dobbins, S; Sherborne, A; Ma, Y; Bardini, M; Biondi, A; Cazzaniga, G; Lloyd, A; Chubb, D; Greaves, M; Houlston, R
Generazione di modelli in vivo per l'identificazione e lo studio di clonalità delle cellule staminali leucemiche nella LAL infant MLL-AF4 positiva
2011 Bardini, M; Corral, L; Woll, P; Wittman, L; Biondi, A; Jacobsen, S; Cazzaniga, G
Identification and characterization of candidate L-ICs IN MLL-AF4 infant all
2011 Bardini, M; Petter, W; Wittmann, L; Corral, L; Biondi, A; Jacobsen, S; Cazzaniga, G